MS
HZNP

Maven Securities’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Maven Securities’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-289,504
Closed -$33.5M – 1268
2023
Q3 		$33.5M Buy
289,504
+248,804
+611% +$26.7M 0.38% 38
2023
Q2 		$4.19M Sell
40,700
-137,678
-77% -$14.5M 0.06% 159
2023
Q1 		$19.5M Sell
178,378
-51,767
-22% -$5.72M 0.41% 41
2022
Q4 		$26.2M Buy
+230,145
New +$19.1M 0.59% 23
2021
Q1 		– Sell
-100,000
Closed -$7.32M – 1414
2020
Q4 		$7.32M Buy
100,000
+86,962
+667% +$6.46M 0.72% 30
2020
Q3 		$1.01M Buy
+13,038
New +$897K 0.08% 239

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Maven Securities's HZNP Position: Q4 2023 in Review

Maven Securities sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 289,504 shares — an estimated $33.5M sold.

Maven Securities first reported a position in HZNP in Q3 2020 and held it in 6 quarters. The position peaked at $33.5M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Maven Securities reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Maven Securities sold 289,504 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $33.5M.
  • Maven Securities first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 6 quarters.
  • Maven Securities's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $33.5M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Maven Securities's 13F filing for Q4 2023, filed 12 Feb 2024.